Insufficient scRNA-seq data for expression of NTRK1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 76% | 249.75 | 196 / 258 | 66% | 66.18 | 152 / 230 |
uterus | 96% | 294.88 | 164 / 170 | 14% | 0.68 | 63 / 459 |
prostate | 99% | 530.01 | 243 / 245 | 10% | 0.15 | 49 / 502 |
lung | 97% | 155.49 | 559 / 578 | 8% | 0.13 | 93 / 1155 |
kidney | 99% | 431.37 | 88 / 89 | 4% | 0.09 | 36 / 901 |
heart | 98% | 240.52 | 845 / 861 | 0% | 0 | 0 / 0 |
pancreas | 73% | 59.72 | 240 / 328 | 24% | 1.19 | 42 / 178 |
intestine | 83% | 175.46 | 804 / 966 | 3% | 0.06 | 15 / 527 |
thymus | 76% | 87.49 | 498 / 653 | 8% | 1.08 | 48 / 605 |
esophagus | 78% | 162.92 | 1120 / 1445 | 1% | 0.02 | 2 / 183 |
breast | 66% | 84.85 | 304 / 459 | 11% | 0.34 | 121 / 1118 |
stomach | 72% | 126.53 | 260 / 359 | 2% | 0.03 | 6 / 286 |
brain | 52% | 108.91 | 1374 / 2642 | 15% | 1.14 | 105 / 705 |
adipose | 67% | 160.09 | 804 / 1204 | 0% | 0 | 0 / 0 |
muscle | 61% | 46.62 | 486 / 803 | 0% | 0 | 0 / 0 |
bladder | 52% | 41.86 | 11 / 21 | 4% | 0.23 | 21 / 504 |
spleen | 46% | 23.45 | 111 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 40% | 39.56 | 536 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 36% | 30.02 | 332 / 929 | 0% | 0 | 0 / 0 |
ovary | 19% | 55.89 | 34 / 180 | 4% | 0.09 | 17 / 430 |
liver | 21% | 9.73 | 48 / 226 | 0% | 0.07 | 2 / 406 |
skin | 4% | 2.26 | 75 / 1809 | 16% | 0.90 | 77 / 472 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.23 | 3 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.09 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0060009 | Biological process | Sertoli cell development |
GO_0007611 | Biological process | learning or memory |
GO_0048011 | Biological process | neurotrophin TRK receptor signaling pathway |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0051599 | Biological process | response to hydrostatic pressure |
GO_0048678 | Biological process | response to axon injury |
GO_0007275 | Biological process | multicellular organism development |
GO_0050966 | Biological process | detection of mechanical stimulus involved in sensory perception of pain |
GO_0060385 | Biological process | axonogenesis involved in innervation |
GO_0061368 | Biological process | behavioral response to formalin induced pain |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0038180 | Biological process | nerve growth factor signaling pathway |
GO_0007623 | Biological process | circadian rhythm |
GO_0038083 | Biological process | peptidyl-tyrosine autophosphorylation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0031667 | Biological process | response to nutrient levels |
GO_0010623 | Biological process | programmed cell death involved in cell development |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0042490 | Biological process | mechanoreceptor differentiation |
GO_0021553 | Biological process | olfactory nerve development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0043068 | Biological process | positive regulation of programmed cell death |
GO_0050965 | Biological process | detection of temperature stimulus involved in sensory perception of pain |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
GO_0071316 | Biological process | cellular response to nicotine |
GO_0006468 | Biological process | protein phosphorylation |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0030183 | Biological process | B cell differentiation |
GO_0007411 | Biological process | axon guidance |
GO_0031902 | Cellular component | late endosome membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0005770 | Cellular component | late endosome |
GO_0010008 | Cellular component | endosome membrane |
GO_0030424 | Cellular component | axon |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005004 | Molecular function | GPI-linked ephrin receptor activity |
GO_0010465 | Molecular function | nerve growth factor receptor activity |
GO_0019900 | Molecular function | kinase binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005166 | Molecular function | neurotrophin p75 receptor binding |
GO_0005030 | Molecular function | neurotrophin receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0043121 | Molecular function | neurotrophin binding |
GO_0005524 | Molecular function | ATP binding |
GO_0048406 | Molecular function | nerve growth factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NTRK1 |
Protein name | Neurotrophic receptor tyrosine kinase 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) Tyrosine-protein kinase receptor (EC 2.7.10.1) |
Synonyms | MTC TRK TRKA |
Description | FUNCTION: Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand . Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation . Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors. .; FUNCTION: [Isoform TrkA-III]: Resistant to NGF, it constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed. . |
Accessions | A0A6Q8PHG5 A0A6Q8PF65 ENST00000674537.2 ENST00000368196.7 [P04629-2] ENST00000358660.3 X5DR71 ENST00000392302.7 ENST00000675461.1 ENST00000531606.2 ENST00000497019.7 A0A6Q8PGU5 X5D991 E9PQG0 ENST00000524377.7 [P04629-1] J3KP20 P04629 |